[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR112015013125A2 - tratamento de lesões orais usando composições de matrix placentário extracelular - Google Patents

tratamento de lesões orais usando composições de matrix placentário extracelular

Info

Publication number
BR112015013125A2
BR112015013125A2 BR112015013125A BR112015013125A BR112015013125A2 BR 112015013125 A2 BR112015013125 A2 BR 112015013125A2 BR 112015013125 A BR112015013125 A BR 112015013125A BR 112015013125 A BR112015013125 A BR 112015013125A BR 112015013125 A2 BR112015013125 A2 BR 112015013125A2
Authority
BR
Brazil
Prior art keywords
treatment
extracellular
oral lesions
matrix compositions
placental matrix
Prior art date
Application number
BR112015013125A
Other languages
English (en)
Inventor
P Gurney Jodi
B Bhatia Mohit
J Hariri Robert
Hofgartner Wolfgang
Original Assignee
Anthrogenesis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anthrogenesis Corp filed Critical Anthrogenesis Corp
Publication of BR112015013125A2 publication Critical patent/BR112015013125A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

resumo tratamento de lesões orais usando composições de matrix placentário extracelular são aqui fornecidos usos de composições compreendendo matriz extracelular (ecm) e as composições que compreendem os componentes de ecm no tratamento de lesões orais não-dentárias. 1/1
BR112015013125A 2012-12-07 2013-12-06 tratamento de lesões orais usando composições de matrix placentário extracelular BR112015013125A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261734665P 2012-12-07 2012-12-07
PCT/US2013/073593 WO2014089440A1 (en) 2012-12-07 2013-12-06 Treating oral lesions using placental extracellular matrix

Publications (1)

Publication Number Publication Date
BR112015013125A2 true BR112015013125A2 (pt) 2017-07-11

Family

ID=50884026

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015013125A BR112015013125A2 (pt) 2012-12-07 2013-12-06 tratamento de lesões orais usando composições de matrix placentário extracelular

Country Status (9)

Country Link
US (1) US20150313948A1 (pt)
EP (2) EP2928481A4 (pt)
JP (4) JP2016501245A (pt)
CN (2) CN104955465A (pt)
BR (1) BR112015013125A2 (pt)
CA (1) CA2894160C (pt)
HK (1) HK1215391A1 (pt)
RU (2) RU2015127077A (pt)
WO (1) WO2014089440A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2897625T3 (da) 2012-09-10 2019-12-16 Univ Wake Forest Health Sciences Amnionmembran og anvendelse deraf til sårheling og tissue engineering-konstrukter
SG11201701114UA (en) * 2014-08-25 2017-03-30 Hli Cellular Therapeutics Llc Extracellular matrix compositions
ES2959455T3 (es) * 2014-10-02 2024-02-26 Wake Forest Univ Health Sciences Inc Polvo de membrana amniótica y su uso en cicatrización de heridas y en construcciones de ingeniería de tejidos
CN110095421B (zh) * 2019-05-17 2022-02-08 淮海工学院 一种胶原蛋白变性温度的测定方法
CN110975010B (zh) * 2019-11-25 2022-02-15 银丰低温医学科技有限公司 一种胎盘组织基质材料及其制备方法
CN111494223A (zh) * 2020-04-22 2020-08-07 福建汉氏联合干细胞科技有限公司 一种胎盘源干细胞漱口修复液

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185011A (en) 1978-10-16 1980-01-22 Firma Carl Freudenberg Process for the production of collagen fibers
DE3042860A1 (de) 1980-11-13 1982-06-09 Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin
FR2516927B1 (fr) 1981-11-26 1986-05-23 Merieux Fond Procede de preparation industrielle de materiaux collageniques a partir de tissus placentaires humains, materiaux collageniques humains obtenus, leur application comme biomateriaux
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4642117A (en) 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US5436135A (en) 1985-09-02 1995-07-25 Pasteur Merieux Serums Et Vaccins New preparation of placenta collagen, their extraction method and their applications
US4852640A (en) 1986-03-28 1989-08-01 Exothermics-Eclipse Inc. Recuperative heat exchanger
US5660692A (en) 1988-02-24 1997-08-26 Cedars-Sinai Medical Center Method of crosslinking amino acid-containing polymers using photoactivatable chemical crosslinkers
US5008116A (en) 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere
FR2692582B1 (fr) 1992-06-18 1998-09-18 Flamel Tech Sa Nouveaux derives reticulables de collagene, leur procede d'obtention et leur application a la preparation de biomateriaux.
US5428022A (en) 1992-07-29 1995-06-27 Collagen Corporation Composition of low type III content human placental collagen
FR2699184B1 (fr) 1992-12-16 1995-03-10 Flamel Tech Sa Nouveaux dérivés de collagène, leur procédé d'obtention et leur application à la préparation de biomatériaux.
WO1997032615A1 (en) 1996-03-04 1997-09-12 Baxter International Inc. Nonpolymeric epoxy compounds for cross-linking biological tissue and bioprosthetic grafts prepared thereby
US5814328A (en) 1997-01-13 1998-09-29 Gunasekaran; Subramanian Preparation of collagen using papain and a reducing agent
US6117979A (en) 1997-08-18 2000-09-12 Medtronic, Inc. Process for making a bioprosthetic device and implants produced therefrom
ES2522890T3 (es) 2000-12-06 2014-11-19 Anthrogenesis Corporation Método para recolectar células troncales placentarias
EP1362095B1 (en) 2001-02-14 2015-05-27 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
JP2003119157A (ja) * 2001-08-06 2003-04-23 Kikuji Yamashita コラーゲンを含有する洗口剤
CA2458821C (en) 2001-08-31 2012-01-10 University Of Southern California Use of non-toxic crosslinking agents to inhibit mechanical degradation of collagenous tissues
US20030124178A1 (en) * 2001-12-28 2003-07-03 Haley Jeffrey T. Soft, adherent, soluble oral patch
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US20060134201A1 (en) * 2004-12-16 2006-06-22 Haley Jeffrey T Collagen troches for treating mouth lesions
EP1919500A2 (en) * 2005-07-13 2008-05-14 Anthrogenesis Corporation Treatment of leg ulcers using placenta derived collagen biofabric
EP2471903B1 (en) 2005-12-29 2018-02-14 Anthrogenesis Corporation Placental stem cell populations
MX354253B (es) * 2006-10-06 2018-02-20 Anthrogenesis Corp Composiciones de colageno placentario (telopeptido), natural.
DE502006006810D1 (de) * 2006-11-06 2010-06-02 Lohmann & Rauscher Gmbh & Co Produkt zur Versorgung von Entzündungen, Druckstellen und/oder Aphten im Oralbereich sowie Verwendung eines solchen Produkts
EP2197270B8 (en) * 2007-09-07 2020-03-04 Surgical Biologics, LLC Placental tissue grafts and improved methods of preparing and using the same
EP2643018B1 (en) * 2010-11-23 2020-10-14 AlderBio Holdings LLC Anti-il-6 antibodies for the treatment of oral mucositis

Also Published As

Publication number Publication date
EP3838280A1 (en) 2021-06-23
EP2928481A4 (en) 2016-09-14
CA2894160A1 (en) 2014-06-12
EP2928481A1 (en) 2015-10-14
CA2894160C (en) 2024-01-02
JP2023065422A (ja) 2023-05-12
WO2014089440A1 (en) 2014-06-12
JP2021073217A (ja) 2021-05-13
RU2019101641A (ru) 2019-03-20
US20150313948A1 (en) 2015-11-05
CN104955465A (zh) 2015-09-30
RU2019101641A3 (pt) 2021-12-28
RU2015127077A (ru) 2017-01-12
HK1215391A1 (zh) 2016-08-26
JP2019108329A (ja) 2019-07-04
JP2016501245A (ja) 2016-01-18
CN117899116A (zh) 2024-04-19

Similar Documents

Publication Publication Date Title
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
BR112013004914A2 (pt) "composições de pele e métodos de uso das mesmas".
HN2011002406A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
CL2014001752A1 (es) Compuestos biciclicos sustituidos; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades tales como cancer, alzheimer, sida, entre otras.
MX2012010253A (es) Composiciones y metodos para tratar y/o prevenir enfermedad cardiovascular.
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
UY34617A (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas
CL2013000018A1 (es) Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros.
EA201391119A1 (ru) Системы доставки наночастиц, их получение и применение
BR112015013125A2 (pt) tratamento de lesões orais usando composições de matrix placentário extracelular
EA201391154A2 (ru) Способы и композиции для нацеливания на адипоциты у млекопитающих
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
CO6630117A2 (es) Anticuerpos contra cxcr4
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
MY193650A (en) Extracellular matrix compositions
CL2014003325A1 (es) Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer
MX2015016410A (es) Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos.
BR112015013675A2 (pt) composições compreendendo vortioxetina e donepezil
BR112014014319A2 (pt) composições de cuidado oral
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
PH12017502404A1 (en) Musk compositions and methods of use thereof
BR112015008389A2 (pt) compostos úteis na síntese de compostos de benzamida
MX2015003074A (es) Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021

B25A Requested transfer of rights approved

Owner name: CELULARITY INC. (US)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.